Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.

Rhea-AI Summary

Danaher (NYSE: DHR) has announced a live video webcast of its Diagnostics Investor and Analyst Meeting scheduled for September 5, 2024 in Washington, D.C. The event will start at approximately 10:00 a.m. ET and will be hosted by Julie Sawyer Montgomery, Executive Vice President of Diagnostics.

Investors and analysts can access the webcast and accompanying slide presentation through the 'Investors' section of Danaher's website, www.danaher.com, under the 'Events & Presentations' subheading. For those unable to attend the live event, a replay of the video webcast will be made available following the presentation.

News Market Reaction

+0.28%

1 alert

+0.28% News Effect

On the day this news was published, DHR gained 0.28%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WASHINGTON, Aug. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Diagnostics Investor and Analyst Meeting in Washington, D.C. on September 5, 2024 beginning at approximately 10:00 a.m. ET. The event will be hosted by Julie Sawyer Montgomery, Executive Vice President, Diagnostics. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the video webcast will be available following the presentation.

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

View original content:https://www.prnewswire.com/news-releases/danaher-to-webcast-diagnostics-investor--analyst-meeting-in-washington-dc-302230841.html

SOURCE Danaher Corporation

FAQ

When is Danaher's (DHR) Diagnostics Investor and Analyst Meeting in 2024?

Danaher's Diagnostics Investor and Analyst Meeting is scheduled for September 5, 2024, in Washington, D.C.

What time does Danaher's (DHR) Diagnostics Investor Meeting start?

The meeting is set to begin at approximately 10:00 a.m. ET on September 5, 2024.

Who will host Danaher's (DHR) Diagnostics Investor and Analyst Meeting?

The event will be hosted by Julie Sawyer Montgomery, Executive Vice President of Diagnostics at Danaher.

How can I access Danaher's (DHR) Diagnostics Investor Meeting webcast?

The webcast can be accessed through the 'Investors' section of Danaher's website, www.danaher.com, under 'Events & Presentations'.

Will there be a replay available for Danaher's (DHR) Diagnostics Investor Meeting?

Yes, a replay of the video webcast will be available on Danaher's website following the presentation.